SCHEMBL7029360

SCHEMBL7029360

COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(OC)c1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 3/20 0.61
KDM4E B2RXH2 8/20 0.55
CYP2C9 P11712 6/20 0.55
HSD17B10 Q99714 6/20 0.55
CYP1A2 P05177 5/20 0.55
CYP3A4 P08684 5/20 0.55
CYP2C19 P33261 5/20 0.55
KMT2A Q03164 4/20 0.55
ALDH1A1 P00352 4/20 0.55
ADORA3 P0DMS8 4/20 0.55
ABCB11 O95342 4/20 0.55
TSHR P16473 4/20 0.55
HIF1A Q16665 3/20 0.55
CYP2D6 P10635 3/20 0.55
SCN5A Q14524 3/20 0.55
HPGD P15428 3/20 0.55
GMNN O75496 2/20 0.55
LMNA P02545 2/20 0.55
TP53 P04637 2/20 0.55
MAPT P10636 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7257040 0.88 KDM4E (0.60) NR1I2KDM4ECYP2C9HSD17B10CYP1A2
SCHEMBL29676206 0.87 NR1I2 (0.73) NR1I2KDM4ECYP2C9HSD17B10CYP1A2
SCHEMBL3034560 0.87 NR1I2 (0.73) NR1I2KDM4ECYP2C9HSD17B10CYP1A2
SCHEMBL7414856 0.82 NR1I2 (0.67) NR1I2KDM4ECYP2C9HSD17B10CYP1A2
SCHEMBL7025790 0.82 NR1I2 (0.56) NR1I2KDM4ECYP2C9HSD17B10CYP1A2
SCHEMBL10367692 0.82 NR1I2 (0.56) NR1I2KDM4ECYP2C9HSD17B10CYP1A2
SCHEMBL11450739 0.79 CYP2C9 (0.79) NR1I2KDM4ECYP2C9HSD17B10CYP1A2
SCHEMBL10829935 0.78 CYP2C9 (0.66) NR1I2KDM4ECYP2C9HSD17B10CYP1A2
SCHEMBL10750223 0.77 NR1I2 (0.60) NR1I2KDM4ECYP2C9HSD17B10CYP1A2
SCHEMBL11450756 0.77 CYP2C9 (0.59) NR1I2KDM4ECYP2C9HSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030230478-A1 Process for the preparation of 1,4 - dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH 2003-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030230478-A1 Process for the preparation of 1,4 - dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents HRH4, ODC1, OGDH NR1I2 712/4885KDM4E 942/4885CYP2C9 493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.